- Previous Close
302.20 - Open
301.00 - Bid --
- Ask --
- Day's Range
278.15 - 301.00 - 52 Week Range
166.43 - 447.70 - Volume
84,192 - Avg. Volume
97,640 - Market Cap (intraday)
36.392B - Beta (5Y Monthly) 0.28
- PE Ratio (TTM)
1,000.00 - EPS (TTM)
0.28 - Earnings Date May 22, 2025 - May 26, 2025
- Forward Dividend & Yield 0.10 (0.04%)
- Ex-Dividend Date Aug 2, 2024
- 1y Target Est
--
Bhagiradha Chemicals & Industries Limited manufactures and sells crop protection chemicals in India, Asia, Australia, and Europe. The company offers insecticides, such as chlorpyrifos, chlorpyrifos-methyl, diafenthiuron, fipronil, dinotefuran, thiamethoxam, imidacloprid, pymetrozine, and chlorantraniliprole; fungicides, including azoxystrobin and trifloxystrobin; herbicides comprising triclopyr, cloquintocet-mexyl, clodinafop-propargyl, sulfosulfuron, and pinoxaden; and specialty intermediates, such as 2,6-dichloroaniline and 2-ethylsulfonylimidazo pyridine-3-sulfonamide. Bhagiradha Chemicals & Industries Limited was incorporated in 1993 and is headquartered in Hyderabad, India.
www.bhagirad.com530
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: BHAGCHEM.NS
View MorePerformance Overview: BHAGCHEM.NS
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BHAGCHEM.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BHAGCHEM.NS
View MoreValuation Measures
Market Cap
36.39B
Enterprise Value
35.62B
Trailing P/E
972.12
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.12
Price/Book (mrq)
5.79
Enterprise Value/Revenue
8.30
Enterprise Value/EBITDA
68.54
Financial Highlights
Profitability and Income Statement
Profit Margin
5.12%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
4.29B
Net Income Avi to Common (ttm)
219.58M
Diluted EPS (ttm)
0.28
Balance Sheet and Cash Flow
Total Cash (mrq)
1.65B
Total Debt/Equity (mrq)
13.98%
Levered Free Cash Flow (ttm)
--